Novel motif:47: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif47_CGAGTN
|novel_motifs_human_sample_pval=11376-118A8_11051;0.723306,11327-117E4_11969;0.92618,11473-119C6_11054;0.440478,11474-119C7_12067;0.582175...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:45, 9 September 2013
name: | motif47_CGAGTN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0005981 | regulation of glycogen catabolic process | 2.747538e-11 |
GO:0071585 | detoxification of cadmium ion | 8.379217e-10 |
GO:0034470 | ncRNA processing | 1.093058e-8 |
GO:0090281 | negative regulation of calcium ion import | 1.226882e-8 |
GO:0071584 | negative regulation of zinc ion import | 1.226882e-8 |
GO:0006364 | rRNA processing | 3.571556e-8 |
GO:0051955 | regulation of amino acid transport | 5.895484e-8 |
GO:0002036 | regulation of L-glutamate transport | 1.050165e-7 |
GO:0034766 | negative regulation of ion transmembrane transport | 1.661821e-7 |
GO:0032060 | bleb assembly | 2.120406e-7 |
GO:0016072 | rRNA metabolic process | 2.221501e-7 |
GO:0090075 | relaxation of muscle | 2.291216e-7 |
GO:0042254 | ribosome biogenesis | 3.897633e-7 |
GO:0002678 | positive regulation of chronic inflammatory response | 4.216360e-7 |
GO:0070574 | cadmium ion transmembrane transport | 5.074433e-7 |
GO:0070979 | protein K11-linked ubiquitination | 1.804715e-6 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2.655361e-6 |
GO:0002676 | regulation of chronic inflammatory response | 2.779058e-6 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 2.944594e-6 |
GO:0015884 | folic acid transport | 3.811967e-6 |
GO:0006288 | base-excision repair, DNA ligation | 4.475891e-6 |
GO:0032790 | ribosome disassembly | 5.078915e-6 |
GO:0032532 | regulation of microvillus length | 5.087262e-6 |
GO:0048561 | establishment of organ orientation | 5.521828e-6 |
GO:0048752 | semicircular canal morphogenesis | 5.772351e-6 |
GO:0021819 | layer formation in cerebral cortex | 6.007234e-6 |
GO:0051299 | centrosome separation | 6.521758e-6 |
GO:0042538 | hyperosmotic salinity response | 7.996980e-6 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 9.613948e-6 |
GO:0031123 | RNA 3'-end processing | 1.260170e-5 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.294338e-5 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 1.353735e-5 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.366651e-5 |
GO:0033169 | histone H3-K9 demethylation | 1.434456e-5 |
GO:0042696 | menarche | 1.444165e-5 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.918088e-5 |
GO:0032581 | ER-dependent peroxisome organization | 1.918482e-5 |
GO:0044070 | regulation of anion transport | 2.100198e-5 |
GO:0043487 | regulation of RNA stability | 2.322514e-5 |
GO:0071557 | histone H3-K27 demethylation | 2.392083e-5 |
GO:0035574 | histone H4-K20 demethylation | 2.392083e-5 |
GO:0051956 | negative regulation of amino acid transport | 2.406377e-5 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 2.663545e-5 |
GO:0001675 | acrosome assembly | 2.858984e-5 |
GO:0051645 | Golgi localization | 2.904789e-5 |
GO:0031124 | mRNA 3'-end processing | 2.953303e-5 |
GO:0046929 | negative regulation of neurotransmitter secretion | 3.196922e-5 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 3.212384e-5 |
GO:0042274 | ribosomal small subunit biogenesis | 3.376105e-5 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 3.516666e-5 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.825453e-5 |
GO:0006021 | inositol biosynthetic process | 4.266476e-5 |
GO:0042694 | muscle cell fate specification | 4.569491e-5 |
GO:0055119 | relaxation of cardiac muscle | 5.100908e-5 |
GO:0043488 | regulation of mRNA stability | 5.418727e-5 |
GO:0046655 | folic acid metabolic process | 5.662376e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 5.894329e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 5.894329e-5 |
GO:0018208 | peptidyl-proline modification | 6.156712e-5 |
GO:0060872 | semicircular canal development | 6.186358e-5 |
GO:0007100 | mitotic centrosome separation | 6.198045e-5 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 6.198045e-5 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.198045e-5 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.198045e-5 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 6.412555e-5 |
GO:0051452 | intracellular pH reduction | 6.818684e-5 |
GO:0040023 | establishment of nucleus localization | 7.320490e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 7.471073e-5 |
GO:0040040 | thermosensory behavior | 8.362187e-5 |
GO:0015742 | alpha-ketoglutarate transport | 1.048052e-4 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 1.115025e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.129808e-4 |
GO:0048291 | isotype switching to IgG isotypes | 1.140851e-4 |
GO:0006844 | acyl carnitine transport | 1.140851e-4 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.140851e-4 |
GO:0002368 | B cell cytokine production | 1.140851e-4 |
GO:0034660 | ncRNA metabolic process | 1.151524e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 1.278635e-4 |
GO:0030490 | maturation of SSU-rRNA | 1.383147e-4 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.514343e-4 |
GO:0045988 | negative regulation of striated muscle contraction | 1.514722e-4 |
GO:0035356 | cellular triglyceride homeostasis | 1.520595e-4 |
GO:0021759 | globus pallidus development | 1.558412e-4 |
GO:0060347 | heart trabecula formation | 1.562527e-4 |
GO:0014911 | positive regulation of smooth muscle cell migration | 1.619801e-4 |
GO:0048713 | regulation of oligodendrocyte differentiation | 1.733000e-4 |
GO:0006447 | regulation of translational initiation by iron | 1.844939e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.951750e-4 |
GO:0051181 | cofactor transport | 2.113750e-4 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 2.167640e-4 |
GO:0048790 | maintenance of presynaptic active zone structure | 2.295497e-4 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 2.295497e-4 |
GO:0046358 | butyrate biosynthetic process | 2.322824e-4 |
GO:0007614 | short-term memory | 2.324763e-4 |
GO:0019087 | transformation of host cell by virus | 2.612378e-4 |
GO:0042989 | sequestering of actin monomers | 2.698662e-4 |
GO:0090346 | cellular organofluorine metabolic process | 2.932252e-4 |
GO:0046210 | nitric oxide catabolic process | 2.932252e-4 |
GO:0043602 | nitrate catabolic process | 2.932252e-4 |
GO:0045851 | pH reduction | 3.162375e-4 |
GO:0097039 | protein linear polyubiquitination | 3.192364e-4 |
GO:0046939 | nucleotide phosphorylation | 3.222011e-4 |
GO:0010626 | negative regulation of Schwann cell proliferation | 3.246893e-4 |
GO:0071460 | cellular response to cell-matrix adhesion | 3.336748e-4 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 3.398203e-4 |
GO:0016340 | calcium-dependent cell-matrix adhesion | 3.425088e-4 |
GO:0043441 | acetoacetic acid biosynthetic process | 3.425088e-4 |
GO:0002002 | regulation of angiotensin levels in blood | 3.595106e-4 |
GO:0060033 | anatomical structure regression | 3.658009e-4 |
GO:0032717 | negative regulation of interleukin-8 production | 3.926028e-4 |
GO:0008033 | tRNA processing | 4.002524e-4 |
GO:0060913 | cardiac cell fate determination | 4.042741e-4 |
GO:0051298 | centrosome duplication | 4.242444e-4 |
GO:0034699 | response to luteinizing hormone stimulus | 4.286642e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 4.353189e-4 |
GO:0051983 | regulation of chromosome segregation | 4.445959e-4 |
GO:0051790 | short-chain fatty acid biosynthetic process | 4.648814e-4 |
GO:0045175 | basal protein localization | 4.648814e-4 |
GO:0007109 | cytokinesis, completion of separation | 4.648814e-4 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 4.868215e-4 |
GO:0000154 | rRNA modification | 4.895968e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 4.916320e-4 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 5.099518e-4 |
GO:0061384 | heart trabecular morphogenesis | 5.230425e-4 |
GO:0022601 | menstrual cycle phase | 5.581151e-4 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 5.907562e-4 |
GO:0060914 | heart formation | 5.952764e-4 |
GO:0008049 | male courtship behavior | 6.553313e-4 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 6.873025e-4 |
GO:0034959 | endothelin maturation | 7.094969e-4 |
GO:0010814 | substance P catabolic process | 7.094969e-4 |
GO:0010816 | calcitonin catabolic process | 7.094969e-4 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.126848e-4 |
GO:0015788 | UDP-N-acetylglucosamine transport | 7.164076e-4 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.203380e-4 |
GO:0060430 | lung saccule development | 7.217804e-4 |
GO:0006482 | protein demethylation | 7.345951e-4 |
GO:0051103 | DNA ligation involved in DNA repair | 7.458444e-4 |
GO:0048384 | retinoic acid receptor signaling pathway | 7.493231e-4 |
GO:0045932 | negative regulation of muscle contraction | 7.542562e-4 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 7.621771e-4 |
GO:0003142 | cardiogenic plate morphogenesis | 7.621771e-4 |
GO:0030421 | defecation | 7.621771e-4 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 7.658920e-4 |
GO:0060042 | retina morphogenesis in camera-type eye | 7.850754e-4 |
GO:0048562 | embryonic organ morphogenesis | 7.993553e-4 |
GO:0030641 | regulation of cellular pH | 8.018398e-4 |
GO:0045948 | positive regulation of translational initiation | 8.213774e-4 |
GO:0033299 | secretion of lysosomal enzymes | 8.763978e-4 |
GO:0006659 | phosphatidylserine biosynthetic process | 8.955810e-4 |
GO:0060087 | relaxation of vascular smooth muscle | 9.076485e-4 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 9.094429e-4 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 9.335693e-4 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 9.612586e-4 |
GO:0048685 | negative regulation of collateral sprouting of intact axon in response to injury | 9.923947e-4 |
GO:0021893 | cerebral cortex GABAergic interneuron fate commitment | 9.923947e-4 |
GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment | 9.923947e-4 |
GO:0045472 | response to ether | 9.981579e-4 |
GO:0035545 | determination of left/right asymmetry in nervous system | 9.981579e-4 |
GO:0046173 | polyol biosynthetic process | 1.003085e-3 |
GO:0044254 | multicellular organismal protein catabolic process | 1.150612e-3 |
GO:0014052 | regulation of gamma-aminobutyric acid secretion | 1.175224e-3 |
GO:0009648 | photoperiodism | 1.175224e-3 |
GO:0050847 | progesterone receptor signaling pathway | 1.231858e-3 |
GO:0060976 | coronary vasculature development | 1.231858e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.242131e-3 |
GO:0060009 | Sertoli cell development | 1.245060e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 1.273874e-3 |
GO:0070543 | response to linoleic acid | 1.319026e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 1.319026e-3 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 1.319026e-3 |
GO:0034696 | response to prostaglandin F stimulus | 1.319026e-3 |
GO:0009440 | cyanate catabolic process | 1.356793e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 1.364541e-3 |
GO:0007379 | segment specification | 1.364596e-3 |
GO:0051958 | methotrexate transport | 1.455369e-3 |
GO:0016557 | peroxisome membrane biogenesis | 1.455369e-3 |
GO:0001977 | renal system process involved in regulation of blood volume | 1.465493e-3 |
GO:0014044 | Schwann cell development | 1.550501e-3 |
GO:0045234 | protein palmitoleylation | 1.557408e-3 |
GO:0006948 | induction by virus of host cell-cell fusion | 1.557408e-3 |
GO:0060911 | cardiac cell fate commitment | 1.579966e-3 |
GO:0045637 | regulation of myeloid cell differentiation | 1.584749e-3 |
GO:0071934 | thiamine transmembrane transport | 1.659530e-3 |
GO:0016598 | protein arginylation | 1.659530e-3 |
GO:0032425 | positive regulation of mismatch repair | 1.688050e-3 |
GO:0001842 | neural fold formation | 1.688050e-3 |
GO:0051660 | establishment of centrosome localization | 1.745033e-3 |
GO:0021540 | corpus callosum morphogenesis | 1.745033e-3 |
GO:0014014 | negative regulation of gliogenesis | 1.745110e-3 |
GO:0010225 | response to UV-C | 1.830433e-3 |
GO:0035025 | positive regulation of Rho protein signal transduction | 1.834158e-3 |
GO:0007097 | nuclear migration | 1.834158e-3 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 1.917550e-3 |
GO:0048664 | neuron fate determination | 1.921327e-3 |
GO:0060998 | regulation of dendritic spine development | 1.922870e-3 |
GO:0007163 | establishment or maintenance of cell polarity | 1.974894e-3 |
GO:0043585 | nose morphogenesis | 2.124952e-3 |
GO:0034389 | lipid particle organization | 2.153766e-3 |
GO:0042373 | vitamin K metabolic process | 2.153766e-3 |
GO:0032988 | ribonucleoprotein complex disassembly | 2.202938e-3 |
GO:0044268 | multicellular organismal protein metabolic process | 2.229033e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 2.265077e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 2.285235e-3 |
GO:0051301 | cell division | 2.303165e-3 |
GO:0030538 | embryonic genitalia morphogenesis | 2.317259e-3 |
GO:0000088 | mitotic prophase | 2.344828e-3 |
GO:0006235 | dTTP biosynthetic process | 2.344828e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 2.374111e-3 |
GO:0018293 | protein-FAD linkage | 2.374111e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 2.374111e-3 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.392590e-3 |
GO:0090307 | spindle assembly involved in mitosis | 2.409463e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 2.414183e-3 |
GO:0031064 | negative regulation of histone deacetylation | 2.450170e-3 |
GO:0032075 | positive regulation of nuclease activity | 2.586717e-3 |
GO:0060318 | definitive erythrocyte differentiation | 2.612597e-3 |
GO:0071529 | cementum mineralization | 2.612597e-3 |
GO:0032859 | activation of Ral GTPase activity | 2.612597e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 2.612597e-3 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 2.616871e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.616871e-3 |
GO:0033126 | positive regulation of GTP catabolic process | 2.617551e-3 |
GO:0033505 | floor plate morphogenesis | 2.755531e-3 |
GO:0006999 | nuclear pore organization | 2.755531e-3 |
GO:0031167 | rRNA methylation | 2.755531e-3 |
GO:0048645 | organ formation | 2.792715e-3 |
GO:0007035 | vacuolar acidification | 2.857198e-3 |
GO:0070509 | calcium ion import | 2.857198e-3 |
GO:0061013 | regulation of mRNA catabolic process | 2.932463e-3 |
GO:0050779 | RNA destabilization | 2.987530e-3 |
GO:0007501 | mesodermal cell fate specification | 2.987530e-3 |
GO:0090241 | negative regulation of histone H4 acetylation | 3.097257e-3 |
GO:0014037 | Schwann cell differentiation | 3.099361e-3 |
GO:2000252 | negative regulation of feeding behavior | 3.124311e-3 |
GO:0072537 | fibroblast activation | 3.124311e-3 |
GO:0048557 | embryonic digestive tract morphogenesis | 3.137375e-3 |
GO:2000109 | regulation of macrophage apoptosis | 3.147483e-3 |
GO:0016577 | histone demethylation | 3.190768e-3 |
GO:0051453 | regulation of intracellular pH | 3.204801e-3 |
GO:0060005 | vestibular reflex | 3.230099e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 3.276507e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 3.327936e-3 |
GO:0061037 | negative regulation of cartilage development | 3.336801e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 3.397498e-3 |
GO:0009584 | detection of visible light | 3.413226e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 3.470372e-3 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 3.575616e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 3.595128e-3 |
GO:0042574 | retinal metabolic process | 3.683077e-3 |
GO:0048313 | Golgi inheritance | 3.684707e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 3.684707e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 3.684707e-3 |
GO:0060486 | Clara cell differentiation | 3.684725e-3 |
GO:0050717 | positive regulation of interleukin-1 alpha secretion | 3.763671e-3 |
GO:0006337 | nucleosome disassembly | 3.963442e-3 |
GO:0001773 | myeloid dendritic cell activation | 3.963442e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 4.054553e-3 |
GO:0040001 | establishment of mitotic spindle localization | 4.108587e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 4.216934e-3 |
GO:0022011 | myelination in peripheral nervous system | 4.217529e-3 |
GO:0001523 | retinoid metabolic process | 4.257082e-3 |
GO:0016101 | diterpenoid metabolic process | 4.316005e-3 |
GO:0034633 | retinol transport | 4.438893e-3 |
GO:0007141 | male meiosis I | 4.458179e-3 |
GO:0002367 | cytokine production involved in immune response | 4.479236e-3 |
GO:0006402 | mRNA catabolic process | 4.524619e-3 |
GO:0048663 | neuron fate commitment | 4.542203e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 4.557685e-3 |
GO:0043171 | peptide catabolic process | 4.606318e-3 |
GO:0060534 | trachea cartilage development | 4.808913e-3 |
GO:0060214 | endocardium formation | 4.808913e-3 |
GO:0032423 | regulation of mismatch repair | 4.813077e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 4.990414e-3 |
GO:0046293 | formaldehyde biosynthetic process | 5.129974e-3 |
GO:0019402 | galactitol metabolic process | 5.129974e-3 |
GO:0045908 | negative regulation of vasodilation | 5.129974e-3 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 5.154843e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5.514750e-3 |
GO:0007522 | visceral muscle development | 5.531748e-3 |
GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 5.557273e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 5.558234e-3 |
GO:0014895 | smooth muscle hypertrophy | 5.573842e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 5.573842e-3 |
GO:0006843 | mitochondrial citrate transport | 5.573842e-3 |
GO:0051293 | establishment of spindle localization | 5.630029e-3 |
GO:0045818 | negative regulation of glycogen catabolic process | 5.732797e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 6.021322e-3 |
GO:0032312 | regulation of ARF GTPase activity | 6.078937e-3 |
GO:0000966 | RNA 5'-end processing | 6.085333e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 6.311431e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 6.312448e-3 |
GO:0060461 | right lung morphogenesis | 6.460414e-3 |
GO:0090131 | mesenchyme migration | 6.460414e-3 |
GO:0060446 | branching involved in open tracheal system development | 6.460414e-3 |
GO:0014822 | detection of wounding | 6.460414e-3 |
GO:0048371 | lateral mesodermal cell differentiation | 6.460414e-3 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 6.460414e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.469682e-3 |
GO:0006930 | substrate-dependent cell migration, cell extension | 6.528060e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 6.641948e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 6.680749e-3 |
GO:0090399 | replicative senescence | 6.690635e-3 |
GO:0051589 | negative regulation of neurotransmitter transport | 6.690635e-3 |
GO:0006265 | DNA topological change | 6.833201e-3 |
GO:0042572 | retinol metabolic process | 6.895285e-3 |
GO:0046015 | regulation of transcription by glucose | 6.913637e-3 |
GO:0000212 | meiotic spindle organization | 7.112998e-3 |
GO:0030220 | platelet formation | 7.130000e-3 |
GO:0006470 | protein dephosphorylation | 7.193388e-3 |
GO:0016311 | dephosphorylation | 7.356399e-3 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 7.406421e-3 |
GO:0045402 | regulation of interleukin-4 biosynthetic process | 7.477567e-3 |
GO:0042780 | tRNA 3'-end processing | 7.514857e-3 |
GO:0042418 | epinephrine biosynthetic process | 7.514857e-3 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 7.514857e-3 |
GO:0032020 | ISG15-protein conjugation | 7.593823e-3 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 7.637872e-3 |
GO:0051647 | nucleus localization | 7.785236e-3 |
GO:0045607 | regulation of auditory receptor cell differentiation | 7.830707e-3 |
GO:0033151 | V(D)J recombination | 7.969388e-3 |
GO:0060487 | lung epithelial cell differentiation | 7.986286e-3 |
GO:0048255 | mRNA stabilization | 8.000673e-3 |
GO:0014028 | notochord formation | 8.007345e-3 |
GO:0032661 | regulation of interleukin-18 production | 8.019930e-3 |
GO:0006885 | regulation of pH | 8.021090e-3 |
GO:0019478 | D-amino acid catabolic process | 8.058992e-3 |
GO:0001830 | trophectodermal cell fate commitment | 8.058992e-3 |
GO:0045684 | positive regulation of epidermis development | 8.173386e-3 |
GO:0001710 | mesodermal cell fate commitment | 8.173386e-3 |
GO:0000183 | chromatin silencing at rDNA | 8.330432e-3 |
GO:0003016 | respiratory system process | 8.372862e-3 |
GO:0060038 | cardiac muscle cell proliferation | 8.511287e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 8.665907e-3 |
GO:0045039 | protein import into mitochondrial inner membrane | 8.708058e-3 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 8.939572e-3 |
GO:0002418 | immune response to tumor cell | 8.939572e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 8.939572e-3 |
GO:0035886 | vascular smooth muscle cell differentiation | 9.018958e-3 |
GO:0014813 | satellite cell commitment | 9.119522e-3 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 9.119522e-3 |
GO:0042214 | terpene metabolic process | 9.119522e-3 |
GO:0060282 | positive regulation of oocyte development | 9.131787e-3 |
GO:0032202 | telomere assembly | 9.146274e-3 |
GO:0072086 | specification of loop of Henle identity | 9.169118e-3 |
GO:0060999 | positive regulation of dendritic spine development | 9.185444e-3 |
GO:0007063 | regulation of sister chromatid cohesion | 9.185444e-3 |
GO:0030826 | regulation of cGMP biosynthetic process | 9.231691e-3 |
GO:0060216 | definitive hemopoiesis | 9.315991e-3 |
GO:0043313 | regulation of neutrophil degranulation | 9.476821e-3 |
GO:0060419 | heart growth | 9.477030e-3 |
GO:0018125 | peptidyl-cysteine methylation | 9.598072e-3 |
GO:0014054 | positive regulation of gamma-aminobutyric acid secretion | 9.598072e-3 |
GO:0001921 | positive regulation of receptor recycling | 9.739907e-3 |
GO:0021801 | cerebral cortex radial glia guided migration | 9.875589e-3 |
GO:0007296 | vitellogenesis | 9.875589e-3 |
GO:0045773 | positive regulation of axon extension | 9.946945e-3 |
GO:0003417 | growth plate cartilage development | 9.961922e-3 |
GO:0042447 | hormone catabolic process | 9.997562e-3 |
GO:0046292 | formaldehyde metabolic process | 1.003139e-2 |
GO:0006401 | RNA catabolic process | 1.010245e-2 |
GO:0071168 | protein localization to chromatin | 1.025388e-2 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.025388e-2 |
GO:0048368 | lateral mesoderm development | 1.025554e-2 |
GO:0070988 | demethylation | 1.068017e-2 |
GO:0016584 | nucleosome positioning | 1.074665e-2 |
GO:0045820 | negative regulation of glycolysis | 1.080597e-2 |
GO:0021895 | cerebral cortex neuron differentiation | 1.090654e-2 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 1.100217e-2 |
GO:0002357 | defense response to tumor cell | 1.101174e-2 |
GO:0060977 | coronary vasculature morphogenesis | 1.116901e-2 |
GO:0030917 | midbrain-hindbrain boundary development | 1.118169e-2 |
GO:0060008 | Sertoli cell differentiation | 1.132143e-2 |
GO:0040030 | regulation of molecular function, epigenetic | 1.155485e-2 |
GO:0003127 | detection of nodal flow | 1.155485e-2 |
GO:0090009 | primitive streak formation | 1.193911e-2 |
GO:0043091 | L-arginine import | 1.207701e-2 |
GO:0070839 | divalent metal ion export | 1.207701e-2 |
GO:0045342 | MHC class II biosynthetic process | 1.207701e-2 |
GO:0006876 | cellular cadmium ion homeostasis | 1.207701e-2 |
GO:0015707 | nitrite transport | 1.207701e-2 |
GO:0032632 | interleukin-3 production | 1.207701e-2 |
GO:0043132 | NAD transport | 1.208754e-2 |
GO:0043923 | positive regulation by host of viral transcription | 1.240110e-2 |
GO:0032730 | positive regulation of interleukin-1 alpha production | 1.242212e-2 |
GO:0001881 | receptor recycling | 1.242212e-2 |
GO:0070873 | regulation of glycogen metabolic process | 1.252638e-2 |
GO:0007098 | centrosome cycle | 1.254211e-2 |
GO:0045663 | positive regulation of myoblast differentiation | 1.254921e-2 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 1.255621e-2 |
GO:0048705 | skeletal system morphogenesis | 1.269998e-2 |
GO:0030309 | poly-N-acetyllactosamine metabolic process | 1.273319e-2 |
GO:0006942 | regulation of striated muscle contraction | 1.284651e-2 |
GO:0060712 | spongiotrophoblast layer development | 1.288163e-2 |
GO:0048568 | embryonic organ development | 1.302876e-2 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 1.317132e-2 |
GO:0006020 | inositol metabolic process | 1.331571e-2 |
GO:0060463 | lung lobe morphogenesis | 1.342937e-2 |
GO:0006310 | DNA recombination | 1.345438e-2 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.347231e-2 |
GO:0006797 | polyphosphate metabolic process | 1.347231e-2 |
GO:0019805 | quinolinate biosynthetic process | 1.368051e-2 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.369265e-2 |
GO:0000132 | establishment of mitotic spindle orientation | 1.371034e-2 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 1.374679e-2 |
GO:0055089 | fatty acid homeostasis | 1.380416e-2 |
GO:0002309 | T cell proliferation involved in immune response | 1.380416e-2 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 1.394611e-2 |
GO:0052314 | phytoalexin metabolic process | 1.395859e-2 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 1.395859e-2 |
GO:0050908 | detection of light stimulus involved in visual perception | 1.395948e-2 |
GO:0006734 | NADH metabolic process | 1.402989e-2 |
GO:0071506 | cellular response to mycophenolic acid | 1.408990e-2 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.408990e-2 |
GO:0051953 | negative regulation of amine transport | 1.412841e-2 |
GO:0090239 | regulation of histone H4 acetylation | 1.433739e-2 |
GO:0048570 | notochord morphogenesis | 1.433739e-2 |
GO:0048617 | embryonic foregut morphogenesis | 1.453975e-2 |
GO:0002019 | regulation of renal output by angiotensin | 1.458760e-2 |
GO:0060711 | labyrinthine layer development | 1.460018e-2 |
GO:0045332 | phospholipid translocation | 1.483453e-2 |
GO:0048619 | embryonic hindgut morphogenesis | 1.500743e-2 |
GO:0006686 | sphingomyelin biosynthetic process | 1.514522e-2 |
GO:0006760 | folic acid-containing compound metabolic process | 1.515601e-2 |
GO:0051549 | positive regulation of keratinocyte migration | 1.520081e-2 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.520081e-2 |
GO:0006287 | base-excision repair, gap-filling | 1.521723e-2 |
GO:0051225 | spindle assembly | 1.533046e-2 |
GO:0045685 | regulation of glial cell differentiation | 1.542481e-2 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 1.548694e-2 |
GO:0043276 | anoikis | 1.548694e-2 |
GO:0060428 | lung epithelium development | 1.563263e-2 |
GO:0014013 | regulation of gliogenesis | 1.563441e-2 |
GO:0032530 | regulation of microvillus organization | 1.575605e-2 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1.584473e-2 |
GO:0021532 | neural tube patterning | 1.652257e-2 |
GO:0051568 | histone H3-K4 methylation | 1.663089e-2 |
GO:0006929 | substrate-dependent cell migration | 1.665751e-2 |
GO:0006882 | cellular zinc ion homeostasis | 1.668026e-2 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 1.677534e-2 |
GO:0048593 | camera-type eye morphogenesis | 1.694068e-2 |
GO:0032007 | negative regulation of TOR signaling cascade | 1.695238e-2 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 1.704935e-2 |
GO:0055017 | cardiac muscle tissue growth | 1.710795e-2 |
GO:0042693 | muscle cell fate commitment | 1.714692e-2 |
GO:0001522 | pseudouridine synthesis | 1.722750e-2 |
GO:0046931 | pore complex assembly | 1.729214e-2 |
GO:0043105 | negative regulation of GTP cyclohydrolase I activity | 1.729791e-2 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 1.729791e-2 |
GO:0035087 | siRNA loading onto RISC involved in RNA interference | 1.729791e-2 |
GO:2000111 | positive regulation of macrophage apoptosis | 1.734370e-2 |
GO:0051297 | centrosome organization | 1.742839e-2 |
GO:0019835 | cytolysis | 1.750073e-2 |
GO:0021670 | lateral ventricle development | 1.758137e-2 |
GO:0021591 | ventricular system development | 1.769499e-2 |
GO:0001845 | phagolysosome assembly | 1.780986e-2 |
GO:0051952 | regulation of amine transport | 1.784738e-2 |
GO:0072384 | organelle transport along microtubule | 1.827031e-2 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.827170e-2 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 1.841806e-2 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.845398e-2 |
GO:0072229 | metanephric proximal convoluted tubule development | 1.849769e-2 |
GO:0071799 | cellular response to prostaglandin D stimulus | 1.849769e-2 |
GO:0060816 | random inactivation of X chromosome | 1.849769e-2 |
GO:0007549 | dosage compensation | 1.852020e-2 |
GO:0060041 | retina development in camera-type eye | 1.870780e-2 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 1.882875e-2 |
GO:0060458 | right lung development | 1.889226e-2 |
GO:0032836 | glomerular basement membrane development | 1.900057e-2 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 1.920161e-2 |
GO:0061162 | establishment of monopolar cell polarity | 1.923604e-2 |
GO:0009651 | response to salt stress | 1.943268e-2 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.947929e-2 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 1.952704e-2 |
GO:0008292 | acetylcholine biosynthetic process | 1.952704e-2 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 2.026265e-2 |
GO:0051798 | positive regulation of hair follicle development | 2.056058e-2 |
GO:0071407 | cellular response to organic cyclic compound | 2.061545e-2 |
GO:0090231 | regulation of spindle checkpoint | 2.063667e-2 |
GO:0006266 | DNA ligation | 2.063667e-2 |
GO:0060479 | lung cell differentiation | 2.064976e-2 |
GO:0043543 | protein acylation | 2.066906e-2 |
GO:0048320 | axial mesoderm formation | 2.070747e-2 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 2.075877e-2 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 2.075877e-2 |
GO:0060242 | contact inhibition | 2.075877e-2 |
GO:0030225 | macrophage differentiation | 2.087919e-2 |
GO:0000959 | mitochondrial RNA metabolic process | 2.092171e-2 |
GO:0035928 | rRNA import into mitochondrion | 2.093476e-2 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.098685e-2 |
GO:0006821 | chloride transport | 2.106037e-2 |
GO:0015872 | dopamine transport | 2.137520e-2 |
GO:0060438 | trachea development | 2.137567e-2 |
GO:0035089 | establishment of apical/basal cell polarity | 2.141125e-2 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 2.141125e-2 |
GO:0042136 | neurotransmitter biosynthetic process | 2.146671e-2 |
GO:0003206 | cardiac chamber morphogenesis | 2.166940e-2 |
GO:0042414 | epinephrine metabolic process | 2.175070e-2 |
GO:0071608 | macrophage inflammatory protein-1 alpha production | 2.175070e-2 |
GO:2000363 | positive regulation of prostaglandin-E synthase activity | 2.175070e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0033239 | negative regulation of cellular amine metabolic process | 5.087033e-12 |
GO:0016072 | rRNA metabolic process | 2.533845e-11 |
GO:0006364 | rRNA processing | 6.684822e-11 |
GO:0042254 | ribosome biogenesis | 1.213490e-10 |
GO:0045963 | negative regulation of dopamine metabolic process | 4.361248e-10 |
GO:0050668 | positive regulation of homocysteine metabolic process | 4.361248e-10 |
GO:0034660 | ncRNA metabolic process | 9.919417e-9 |
GO:0071843 | cellular component biogenesis at cellular level | 4.308772e-8 |
GO:0032418 | lysosome localization | 4.729760e-8 |
GO:0022613 | ribonucleoprotein complex biogenesis | 7.914233e-8 |
GO:0006396 | RNA processing | 1.160814e-7 |
GO:0031167 | rRNA methylation | 1.922333e-7 |
GO:0034470 | ncRNA processing | 1.960799e-7 |
GO:0051176 | positive regulation of sulfur metabolic process | 6.584683e-7 |
GO:0000154 | rRNA modification | 1.343611e-6 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 2.314629e-6 |
GO:0042424 | catecholamine catabolic process | 2.466051e-6 |
GO:0010498 | proteasomal protein catabolic process | 2.595797e-6 |
GO:0010467 | gene expression | 3.342525e-6 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 4.015976e-6 |
GO:0022417 | protein maturation by protein folding | 4.015976e-6 |
GO:0019047 | provirus integration | 7.263368e-6 |
GO:0090304 | nucleic acid metabolic process | 7.483733e-6 |
GO:0007049 | cell cycle | 8.810440e-6 |
GO:0044260 | cellular macromolecule metabolic process | 1.052194e-5 |
GO:0016070 | RNA metabolic process | 1.530563e-5 |
GO:0044265 | cellular macromolecule catabolic process | 2.016059e-5 |
GO:0070574 | cadmium ion transmembrane transport | 2.203699e-5 |
GO:0051303 | establishment of chromosome localization | 2.247464e-5 |
GO:0043558 | regulation of translational initiation in response to stress | 2.253408e-5 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 2.363713e-5 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.735538e-5 |
GO:0030163 | protein catabolic process | 2.975333e-5 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 3.176675e-5 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 3.176675e-5 |
GO:0034447 | very-low-density lipoprotein particle clearance | 3.507243e-5 |
GO:0006413 | translational initiation | 4.251695e-5 |
GO:0044257 | cellular protein catabolic process | 4.724973e-5 |
GO:0051310 | metaphase plate congression | 4.761740e-5 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 8.805305e-5 |
GO:0033091 | positive regulation of immature T cell proliferation | 1.032581e-4 |
GO:0045764 | positive regulation of cellular amino acid metabolic process | 1.062846e-4 |
GO:0045116 | protein neddylation | 1.100092e-4 |
GO:0022403 | cell cycle phase | 1.117060e-4 |
GO:0043153 | entrainment of circadian clock by photoperiod | 1.127770e-4 |
GO:0070634 | transepithelial ammonium transport | 1.207387e-4 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.230290e-4 |
GO:0032288 | myelin assembly | 1.265567e-4 |
GO:0021871 | forebrain regionalization | 1.329313e-4 |
GO:0006783 | heme biosynthetic process | 1.335999e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 1.339567e-4 |
GO:0008380 | RNA splicing | 1.388618e-4 |
GO:0072061 | inner medullary collecting duct development | 1.397983e-4 |
GO:0072060 | outer medullary collecting duct development | 1.397983e-4 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1.397983e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.475231e-4 |
GO:0010891 | negative regulation of sequestering of triglyceride | 1.489873e-4 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.570085e-4 |
GO:0060535 | trachea cartilage morphogenesis | 1.673831e-4 |
GO:0010889 | regulation of sequestering of triglyceride | 1.719247e-4 |
GO:0032289 | central nervous system myelin formation | 1.735453e-4 |
GO:0009648 | photoperiodism | 1.735453e-4 |
GO:0015696 | ammonium transport | 1.796855e-4 |
GO:0072488 | ammonium transmembrane transport | 1.918529e-4 |
GO:0060482 | lobar bronchus development | 1.918529e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.957311e-4 |
GO:0044267 | cellular protein metabolic process | 1.993674e-4 |
GO:0042420 | dopamine catabolic process | 2.054663e-4 |
GO:0010468 | regulation of gene expression | 2.121845e-4 |
GO:0060534 | trachea cartilage development | 2.155808e-4 |
GO:0051568 | histone H3-K4 methylation | 2.315028e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.363166e-4 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.404877e-4 |
GO:0010870 | positive regulation of receptor biosynthetic process | 2.494008e-4 |
GO:0019941 | modification-dependent protein catabolic process | 2.628392e-4 |
GO:0007501 | mesodermal cell fate specification | 2.629490e-4 |
GO:0032922 | circadian regulation of gene expression | 2.629490e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.802202e-4 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.079582e-4 |
GO:0000726 | non-recombinational repair | 3.079636e-4 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 3.160481e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.605890e-4 |
GO:0010556 | regulation of macromolecule biosynthetic process | 3.657039e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 3.773285e-4 |
GO:0009057 | macromolecule catabolic process | 3.980031e-4 |
GO:0007614 | short-term memory | 4.103781e-4 |
GO:0090042 | tubulin deacetylation | 4.777579e-4 |
GO:0070846 | Hsp90 deacetylation | 4.777579e-4 |
GO:0045072 | regulation of interferon-gamma biosynthetic process | 4.806186e-4 |
GO:2000971 | negative regulation of detection of glucose | 4.810999e-4 |
GO:2000976 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose | 4.810999e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.810999e-4 |
GO:0000433 | negative regulation of transcription from RNA polymerase II promoter by glucose | 4.810999e-4 |
GO:0070165 | positive regulation of adiponectin secretion | 5.003742e-4 |
GO:0033031 | positive regulation of neutrophil apoptosis | 5.003742e-4 |
GO:0022402 | cell cycle process | 5.317930e-4 |
GO:0032929 | negative regulation of superoxide anion generation | 5.363089e-4 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 5.392177e-4 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 5.392177e-4 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 5.392177e-4 |
GO:0006268 | DNA unwinding involved in replication | 5.653047e-4 |
GO:0016071 | mRNA metabolic process | 5.674246e-4 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 5.754647e-4 |
GO:0006713 | glucocorticoid catabolic process | 6.081873e-4 |
GO:0032060 | bleb assembly | 6.495203e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 6.795003e-4 |
GO:0043060 | meiotic metaphase I plate congression | 7.077601e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 7.553921e-4 |
GO:0060433 | bronchus development | 7.574025e-4 |
GO:0048665 | neuron fate specification | 7.593902e-4 |
GO:0006261 | DNA-dependent DNA replication | 7.998834e-4 |
GO:0060439 | trachea morphogenesis | 8.104127e-4 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.125130e-4 |
GO:0032928 | regulation of superoxide anion generation | 8.127967e-4 |
GO:0000279 | M phase | 8.284144e-4 |
GO:0010869 | regulation of receptor biosynthetic process | 8.972243e-4 |
GO:0010608 | posttranscriptional regulation of gene expression | 9.585253e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 9.616447e-4 |
GO:0048478 | replication fork protection | 9.841941e-4 |
GO:0034501 | protein localization to kinetochore | 9.981952e-4 |
GO:0008611 | ether lipid biosynthetic process | 1.031841e-3 |
GO:0033083 | regulation of immature T cell proliferation | 1.086791e-3 |
GO:0048477 | oogenesis | 1.090282e-3 |
GO:0072054 | renal outer medulla development | 1.102048e-3 |
GO:0006306 | DNA methylation | 1.121854e-3 |
GO:0072053 | renal inner medulla development | 1.187579e-3 |
GO:0043555 | regulation of translation in response to stress | 1.187579e-3 |
GO:0032924 | activin receptor signaling pathway | 1.187579e-3 |
GO:0051301 | cell division | 1.264419e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.268450e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 1.268611e-3 |
GO:0072205 | metanephric collecting duct development | 1.273296e-3 |
GO:0042168 | heme metabolic process | 1.300390e-3 |
GO:0035566 | regulation of metanephros size | 1.365837e-3 |
GO:0006397 | mRNA processing | 1.373169e-3 |
GO:0014895 | smooth muscle hypertrophy | 1.378900e-3 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 1.378900e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 1.378900e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.386205e-3 |
GO:0016568 | chromatin modification | 1.407632e-3 |
GO:0009649 | entrainment of circadian clock | 1.421530e-3 |
GO:0015780 | nucleotide-sugar transport | 1.470629e-3 |
GO:0070544 | histone H3-K36 demethylation | 1.593436e-3 |
GO:0009451 | RNA modification | 1.598937e-3 |
GO:0043412 | macromolecule modification | 1.619631e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 1.649958e-3 |
GO:0006507 | GPI anchor release | 1.649958e-3 |
GO:0042178 | xenobiotic catabolic process | 1.683640e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.683640e-3 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.737645e-3 |
GO:0002089 | lens morphogenesis in camera-type eye | 1.760980e-3 |
GO:0070179 | D-serine biosynthetic process | 1.802661e-3 |
GO:0009088 | threonine biosynthetic process | 1.802661e-3 |
GO:0010887 | negative regulation of cholesterol storage | 1.804365e-3 |
GO:0071243 | cellular response to arsenic-containing substance | 1.806703e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 1.836322e-3 |
GO:0051594 | detection of glucose | 1.933866e-3 |
GO:0055015 | ventricular cardiac muscle cell development | 1.965662e-3 |
GO:0060425 | lung morphogenesis | 2.000182e-3 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 2.111603e-3 |
GO:0032259 | methylation | 2.115923e-3 |
GO:0034587 | piRNA metabolic process | 2.168903e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 2.170970e-3 |
GO:0001510 | RNA methylation | 2.333566e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 2.343878e-3 |
GO:0030521 | androgen receptor signaling pathway | 2.373743e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 2.419588e-3 |
GO:0030421 | defecation | 2.513259e-3 |
GO:0006493 | protein O-linked glycosylation | 2.568870e-3 |
GO:0001705 | ectoderm formation | 2.591540e-3 |
GO:0019222 | regulation of metabolic process | 2.616565e-3 |
GO:0080090 | regulation of primary metabolic process | 2.642056e-3 |
GO:0031323 | regulation of cellular metabolic process | 2.668155e-3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 2.668530e-3 |
GO:0031326 | regulation of cellular biosynthetic process | 2.678492e-3 |
GO:0035063 | nuclear speck organization | 2.700163e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 2.700163e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 2.700163e-3 |
GO:0007080 | mitotic metaphase plate congression | 2.722477e-3 |
GO:0006325 | chromatin organization | 2.774723e-3 |
GO:0006904 | vesicle docking involved in exocytosis | 2.790767e-3 |
GO:0016567 | protein ubiquitination | 2.829948e-3 |
GO:0035967 | cellular response to topologically incorrect protein | 2.855198e-3 |
GO:0031507 | heterochromatin formation | 2.867250e-3 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 2.956459e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 2.956459e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 2.956459e-3 |
GO:0071585 | detoxification of cadmium ion | 3.027427e-3 |
GO:0000255 | allantoin metabolic process | 3.084813e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 3.200713e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 3.205871e-3 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.206217e-3 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 3.230114e-3 |
GO:0009103 | lipopolysaccharide biosynthetic process | 3.265213e-3 |
GO:0060255 | regulation of macromolecule metabolic process | 3.285142e-3 |
GO:0090286 | cytoskeletal anchoring at nuclear membrane | 3.411680e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 3.411680e-3 |
GO:0033132 | negative regulation of glucokinase activity | 3.411680e-3 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 3.411680e-3 |
GO:0006417 | regulation of translation | 3.448846e-3 |
GO:0032508 | DNA duplex unwinding | 3.491691e-3 |
GO:0000819 | sister chromatid segregation | 3.583079e-3 |
GO:0070627 | ferrous iron import | 3.675936e-3 |
GO:0046416 | D-amino acid metabolic process | 3.675936e-3 |
GO:0015692 | lead ion transport | 3.675936e-3 |
GO:0015676 | vanadium ion transport | 3.675936e-3 |
GO:0006450 | regulation of translational fidelity | 3.696365e-3 |
GO:0090193 | positive regulation of glomerulus development | 3.837469e-3 |
GO:0061015 | snRNA import into nucleus | 3.940058e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 3.940058e-3 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 3.940058e-3 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 3.980635e-3 |
GO:0042135 | neurotransmitter catabolic process | 4.071347e-3 |
GO:0032099 | negative regulation of appetite | 4.240539e-3 |
GO:0090402 | oncogene-induced senescence | 4.290902e-3 |
GO:2000774 | positive regulation of cellular senescence | 4.290902e-3 |
GO:0035986 | senescence-associated heterochromatin focus formation | 4.290902e-3 |
GO:0072215 | regulation of metanephros development | 4.382459e-3 |
GO:0032392 | DNA geometric change | 4.524492e-3 |
GO:0070076 | histone lysine demethylation | 4.536046e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 4.577971e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 4.755456e-3 |
GO:0071480 | cellular response to gamma radiation | 4.877971e-3 |
GO:0032096 | negative regulation of response to food | 4.877971e-3 |
GO:0043984 | histone H4-K16 acetylation | 4.948590e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 4.948590e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 4.985069e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 5.086574e-3 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 5.127715e-3 |
GO:0034382 | chylomicron remnant clearance | 5.141873e-3 |
GO:0060536 | cartilage morphogenesis | 5.376534e-3 |
GO:0042231 | interleukin-13 biosynthetic process | 5.435160e-3 |
GO:2000256 | positive regulation of male germ cell proliferation | 5.435160e-3 |
GO:0019858 | cytosine metabolic process | 5.435160e-3 |
GO:0019428 | allantoin biosynthetic process | 5.435160e-3 |
GO:0007066 | female meiosis sister chromatid cohesion | 5.435160e-3 |
GO:0000070 | mitotic sister chromatid segregation | 5.571623e-3 |
GO:0022406 | membrane docking | 5.591286e-3 |
GO:0030575 | nuclear body organization | 5.640749e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 5.667398e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 5.691413e-3 |
GO:0042053 | regulation of dopamine metabolic process | 5.730429e-3 |
GO:0035305 | negative regulation of dephosphorylation | 5.752388e-3 |
GO:0015879 | carnitine transport | 5.889474e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 5.907424e-3 |
GO:0006464 | protein modification process | 5.912814e-3 |
GO:0003254 | regulation of membrane depolarization | 6.129537e-3 |
GO:0051252 | regulation of RNA metabolic process | 6.235928e-3 |
GO:0016574 | histone ubiquitination | 6.247017e-3 |
GO:0008210 | estrogen metabolic process | 6.300781e-3 |
GO:0031503 | protein complex localization | 6.301517e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 6.318822e-3 |
GO:0046685 | response to arsenic-containing substance | 6.445565e-3 |
GO:0000729 | DNA double-strand break processing | 6.494527e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 6.494527e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 6.494527e-3 |
GO:0000089 | mitotic metaphase | 6.494527e-3 |
GO:0033240 | positive regulation of cellular amine metabolic process | 6.530956e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 6.631404e-3 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6.697104e-3 |
GO:0006505 | GPI anchor metabolic process | 6.730409e-3 |
GO:0006264 | mitochondrial DNA replication | 6.757179e-3 |
GO:0000239 | pachytene | 6.757179e-3 |
GO:0051972 | regulation of telomerase activity | 6.784083e-3 |
GO:0045070 | positive regulation of viral genome replication | 6.804249e-3 |
GO:0051276 | chromosome organization | 6.908989e-3 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 6.990840e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 7.012548e-3 |
GO:0042360 | vitamin E metabolic process | 7.082715e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 7.082715e-3 |
GO:2000678 | negative regulation of transcription regulatory region DNA binding | 7.345424e-3 |
GO:0048285 | organelle fission | 7.377950e-3 |
GO:0000278 | mitotic cell cycle | 7.698270e-3 |
GO:0008366 | axon ensheathment | 7.713969e-3 |
GO:0007059 | chromosome segregation | 7.758887e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 7.972723e-3 |
GO:0048278 | vesicle docking | 8.037054e-3 |
GO:0018202 | peptidyl-histidine modification | 8.279663e-3 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 8.361287e-3 |
GO:0070842 | aggresome assembly | 8.372446e-3 |
GO:0045918 | negative regulation of cytolysis | 8.372446e-3 |
GO:0051973 | positive regulation of telomerase activity | 8.372446e-3 |
GO:0007131 | reciprocal meiotic recombination | 8.398395e-3 |
GO:0006448 | regulation of translational elongation | 8.596108e-3 |
GO:0009889 | regulation of biosynthetic process | 8.608150e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 8.833517e-3 |
GO:0060586 | multicellular organismal iron ion homeostasis | 8.833517e-3 |
GO:0031915 | positive regulation of synaptic plasticity | 8.893077e-3 |
GO:0060037 | pharyngeal system development | 8.897701e-3 |
GO:0070163 | regulation of adiponectin secretion | 8.995932e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 8.995932e-3 |
GO:0060084 | synaptic transmission involved in micturition | 8.995932e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 8.995932e-3 |
GO:0006682 | galactosylceramide biosynthetic process | 8.995932e-3 |
GO:0016577 | histone demethylation | 9.086806e-3 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 9.099584e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 9.099584e-3 |
GO:0031577 | spindle checkpoint | 9.233836e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 9.324238e-3 |
GO:0071557 | histone H3-K27 demethylation | 9.526742e-3 |
GO:0035574 | histone H4-K20 demethylation | 9.526742e-3 |
GO:0035518 | histone H2A monoubiquitination | 9.593738e-3 |
GO:0051318 | G1 phase | 9.879778e-3 |
GO:0070672 | response to interleukin-15 | 9.945679e-3 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 1.003344e-2 |
GO:0001841 | neural tube formation | 1.005659e-2 |
GO:0009059 | macromolecule biosynthetic process | 1.009708e-2 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.010091e-2 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.010091e-2 |
GO:0072236 | metanephric loop of Henle development | 1.030656e-2 |
GO:0060033 | anatomical structure regression | 1.039953e-2 |
GO:0090319 | positive regulation of chylomicron remodeling | 1.044098e-2 |
GO:0090321 | positive regulation of chylomicron remnant clearance | 1.044098e-2 |
GO:0033315 | meiotic cell cycle DNA replication checkpoint | 1.044098e-2 |
GO:0010032 | meiotic chromosome condensation | 1.044098e-2 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.048216e-2 |
GO:0034201 | response to oleic acid | 1.051281e-2 |
GO:0035444 | nickel ion transmembrane transport | 1.062058e-2 |
GO:0043170 | macromolecule metabolic process | 1.077607e-2 |
GO:0032277 | negative regulation of gonadotropin secretion | 1.086022e-2 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.086022e-2 |
GO:0016570 | histone modification | 1.148039e-2 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.151822e-2 |
GO:0042069 | regulation of catecholamine metabolic process | 1.166127e-2 |
GO:0045773 | positive regulation of axon extension | 1.172834e-2 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 1.183637e-2 |
GO:0048663 | neuron fate commitment | 1.186684e-2 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.187722e-2 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1.203453e-2 |
GO:0021549 | cerebellum development | 1.228801e-2 |
GO:0045132 | meiotic chromosome segregation | 1.249826e-2 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 1.251194e-2 |
GO:0032107 | regulation of response to nutrient levels | 1.256995e-2 |
GO:0040029 | regulation of gene expression, epigenetic | 1.265890e-2 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.267666e-2 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.275939e-2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1.294692e-2 |
GO:0035434 | copper ion transmembrane transport | 1.313132e-2 |
GO:0018342 | protein prenylation | 1.321065e-2 |
GO:0001810 | regulation of type I hypersensitivity | 1.321065e-2 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.327649e-2 |
GO:0032571 | response to vitamin K | 1.327649e-2 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.349895e-2 |
GO:0007067 | mitosis | 1.351408e-2 |
GO:0090218 | positive regulation of lipid kinase activity | 1.358718e-2 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.379145e-2 |
GO:0014805 | smooth muscle adaptation | 1.379145e-2 |
GO:0070671 | response to interleukin-12 | 1.385749e-2 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.385749e-2 |
GO:0051188 | cofactor biosynthetic process | 1.387341e-2 |
GO:0070845 | polyubiquitinated misfolded protein transport | 1.389474e-2 |
GO:0009107 | lipoate biosynthetic process | 1.389474e-2 |
GO:0051466 | positive regulation of corticotropin-releasing hormone secretion | 1.389474e-2 |
GO:0048705 | skeletal system morphogenesis | 1.464535e-2 |
GO:0060562 | epithelial tube morphogenesis | 1.472009e-2 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 1.479919e-2 |
GO:0006351 | transcription, DNA-dependent | 1.489572e-2 |
GO:0045143 | homologous chromosome segregation | 1.499022e-2 |
GO:0030513 | positive regulation of BMP signaling pathway | 1.504454e-2 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 1.511033e-2 |
GO:0009952 | anterior/posterior pattern specification | 1.522988e-2 |
GO:0018105 | peptidyl-serine phosphorylation | 1.530467e-2 |
GO:0061162 | establishment of monopolar cell polarity | 1.554449e-2 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.591190e-2 |
GO:0042696 | menarche | 1.591190e-2 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.591190e-2 |
GO:0017004 | cytochrome complex assembly | 1.591190e-2 |
GO:0009106 | lipoate metabolic process | 1.595484e-2 |
GO:0033211 | adiponectin-mediated signaling pathway | 1.604260e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.625914e-2 |
GO:0006482 | protein demethylation | 1.635345e-2 |
GO:0021562 | vestibulocochlear nerve development | 1.637649e-2 |
GO:0090192 | regulation of glomerulus development | 1.646071e-2 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.652882e-2 |
GO:0045666 | positive regulation of neuron differentiation | 1.655579e-2 |
GO:0016569 | covalent chromatin modification | 1.676154e-2 |
GO:0060096 | serotonin secretion, neurotransmission | 1.682027e-2 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 1.682027e-2 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 1.682027e-2 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.682027e-2 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 1.682027e-2 |
GO:0045609 | positive regulation of auditory receptor cell differentiation | 1.682027e-2 |
GO:2000682 | positive regulation of rubidium ion transport | 1.682027e-2 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 1.682027e-2 |
GO:0060717 | chorion development | 1.682027e-2 |
GO:0042667 | auditory receptor cell fate specification | 1.682027e-2 |
GO:0003236 | sinus venosus morphogenesis | 1.682027e-2 |
GO:0003210 | cardiac atrium formation | 1.682027e-2 |
GO:0035826 | rubidium ion transport | 1.682027e-2 |
GO:0003259 | cardioblast anterior-lateral migration | 1.682027e-2 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.682027e-2 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 1.682027e-2 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 1.682027e-2 |
GO:0010430 | fatty acid omega-oxidation | 1.682027e-2 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 1.684012e-2 |
GO:0031047 | gene silencing by RNA | 1.686510e-2 |
GO:2000036 | regulation of stem cell maintenance | 1.695256e-2 |
GO:0032774 | RNA biosynthetic process | 1.705299e-2 |
GO:0060347 | heart trabecula formation | 1.721018e-2 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.737674e-2 |
GO:0000002 | mitochondrial genome maintenance | 1.775508e-2 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 1.779553e-2 |
GO:0045669 | positive regulation of osteoblast differentiation | 1.801271e-2 |
GO:0006563 | L-serine metabolic process | 1.833209e-2 |
GO:0043116 | negative regulation of vascular permeability | 1.841044e-2 |
GO:0007031 | peroxisome organization | 1.847587e-2 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 1.853965e-2 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 1.853965e-2 |
GO:0060179 | male mating behavior | 1.853965e-2 |
GO:0035519 | protein K29-linked ubiquitination | 1.853965e-2 |
GO:0051030 | snRNA transport | 1.853965e-2 |
GO:0051257 | spindle midzone assembly involved in meiosis | 1.853965e-2 |
GO:0000087 | M phase of mitotic cell cycle | 1.863843e-2 |
GO:0051325 | interphase | 1.886691e-2 |
GO:0042268 | regulation of cytolysis | 1.899020e-2 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.899020e-2 |
GO:0051546 | keratinocyte migration | 1.916661e-2 |
GO:0014012 | peripheral nervous system axon regeneration | 1.921378e-2 |
GO:0006101 | citrate metabolic process | 1.929727e-2 |
GO:0042273 | ribosomal large subunit biogenesis | 1.929727e-2 |
GO:0033169 | histone H3-K9 demethylation | 1.929727e-2 |
GO:0060438 | trachea development | 1.946067e-2 |
GO:0045663 | positive regulation of myoblast differentiation | 1.946067e-2 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 1.994231e-2 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 1.994231e-2 |
GO:0006235 | dTTP biosynthetic process | 1.994231e-2 |
GO:0003105 | negative regulation of glomerular filtration | 1.994231e-2 |
GO:0002019 | regulation of renal output by angiotensin | 1.995506e-2 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 2.008218e-2 |
GO:0000076 | DNA replication checkpoint | 2.008218e-2 |
GO:0001555 | oocyte growth | 2.008218e-2 |
GO:0006402 | mRNA catabolic process | 2.013664e-2 |
GO:0051329 | interphase of mitotic cell cycle | 2.032089e-2 |
GO:0060364 | frontal suture morphogenesis | 2.032308e-2 |
GO:0019374 | galactolipid metabolic process | 2.032308e-2 |
GO:0018209 | peptidyl-serine modification | 2.038655e-2 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.039040e-2 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 2.059853e-2 |
GO:0002663 | positive regulation of B cell tolerance induction | 2.059853e-2 |
GO:0032859 | activation of Ral GTPase activity | 2.059853e-2 |
GO:0006260 | DNA replication | 2.067762e-2 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.083742e-2 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 2.095493e-2 |
GO:0051351 | positive regulation of ligase activity | 2.129443e-2 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 2.145629e-2 |
GO:0006573 | valine metabolic process | 2.145629e-2 |
GO:0050685 | positive regulation of mRNA processing | 2.161748e-2 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.176794e-2 |
GO:0021521 | ventral spinal cord interneuron specification | 2.201259e-2 |
GO:0070633 | transepithelial transport | 2.230794e-2 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 2.242968e-2 |
GO:0006399 | tRNA metabolic process | 2.244234e-2 |
GO:0021759 | globus pallidus development | 2.247062e-2 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 2.265877e-2 |
GO:0046580 | negative regulation of Ras protein signal transduction | 2.278561e-2 |
GO:0015695 | organic cation transport | 2.312068e-2 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 2.327541e-2 |
GO:0060192 | negative regulation of lipase activity | 2.373625e-2 |
GO:0042552 | myelination | 2.376677e-2 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 2.390661e-2 |
GO:0071421 | manganese ion transmembrane transport | 2.390661e-2 |
GO:0001839 | neural plate morphogenesis | 2.395916e-2 |
GO:0070979 | protein K11-linked ubiquitination | 2.398427e-2 |
GO:0050691 | regulation of defense response to virus by host | 2.400192e-2 |
GO:0046836 | glycolipid transport | 2.410019e-2 |
GO:0061360 | optic chiasma development | 2.410019e-2 |
GO:2000597 | positive regulation of optic nerve formation | 2.410019e-2 |
GO:0090292 | nuclear matrix anchoring at nuclear membrane | 2.410019e-2 |
GO:0042095 | interferon-gamma biosynthetic process | 2.410019e-2 |
GO:0035799 | ureter maturation | 2.410019e-2 |
GO:0021633 | optic nerve structural organization | 2.410019e-2 |
GO:0016340 | calcium-dependent cell-matrix adhesion | 2.410019e-2 |
GO:0021650 | vestibulocochlear nerve formation | 2.410019e-2 |
GO:0046939 | nucleotide phosphorylation | 2.424118e-2 |
GO:0032479 | regulation of type I interferon production | 2.433200e-2 |
GO:0006730 | one-carbon metabolic process | 2.440999e-2 |
GO:0033131 | regulation of glucokinase activity | 2.446474e-2 |
GO:0007509 | mesoderm migration involved in gastrulation | 2.470922e-2 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 2.479032e-2 |
GO:0021797 | forebrain anterior/posterior pattern specification | 2.479032e-2 |
GO:0045950 | negative regulation of mitotic recombination | 2.487783e-2 |
GO:0003406 | retinal pigment epithelium development | 2.487783e-2 |
GO:0040019 | positive regulation of embryonic development | 2.526698e-2 |
GO:0051457 | maintenance of protein location in nucleus | 2.556168e-2 |
GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 2.562589e-2 |
GO:0032364 | oxygen homeostasis | 2.578209e-2 |
GO:0042133 | neurotransmitter metabolic process | 2.584699e-2 |
GO:0003002 | regionalization | 2.602059e-2 |
GO:0030033 | microvillus assembly | 2.637675e-2 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 2.637675e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 2.637675e-2 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 2.682213e-2 |
GO:0071169 | establishment of protein localization to chromatin | 2.721813e-2 |
GO:0051790 | short-chain fatty acid biosynthetic process | 2.721813e-2 |
GO:2000781 | positive regulation of double-strand break repair | 2.721813e-2 |
GO:0032621 | interleukin-18 production | 2.721813e-2 |
GO:0007506 | gonadal mesoderm development | 2.721813e-2 |
GO:0032383 | regulation of intracellular cholesterol transport | 2.721813e-2 |
GO:0001546 | preantral ovarian follicle growth | 2.721813e-2 |
GO:0018344 | protein geranylgeranylation | 2.721813e-2 |